nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—HTR2C—endogenous depression	0.372	0.415	CbGaD
Dexfenfluramine—SLC6A4—endogenous depression	0.309	0.344	CbGaD
Dexfenfluramine—CYP2D6—endogenous depression	0.217	0.242	CbGaD
Dexfenfluramine—Cinacalcet—CYP2D6—endogenous depression	0.0014	0.341	CrCbGaD
Dexfenfluramine—Methamphetamine—MAOA—endogenous depression	0.00129	0.314	CrCbGaD
Dexfenfluramine—HTR2C—brainstem—endogenous depression	0.000835	0.0471	CbGeAlD
Dexfenfluramine—Methamphetamine—SLC6A4—endogenous depression	0.00083	0.202	CrCbGaD
Dexfenfluramine—HTR2C—forebrain—endogenous depression	0.000806	0.0455	CbGeAlD
Dexfenfluramine—SLC6A4—brainstem—endogenous depression	0.000792	0.0447	CbGeAlD
Dexfenfluramine—SLC6A4—forebrain—endogenous depression	0.000764	0.0431	CbGeAlD
Dexfenfluramine—HTR2B—forebrain—endogenous depression	0.000757	0.0427	CbGeAlD
Dexfenfluramine—HTR2C—Monoamine GPCRs—HTR7—endogenous depression	0.000724	0.00902	CbGpPWpGaD
Dexfenfluramine—HTR2C—Amine ligand-binding receptors—HTR1A—endogenous depression	0.00072	0.00897	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Methylation—COMT—endogenous depression	0.000711	0.00885	CbGpPWpGaD
Dexfenfluramine—HTR2B—adrenal cortex—endogenous depression	0.000702	0.0396	CbGeAlD
Dexfenfluramine—CYP2C19—Xenobiotics—CYP2D6—endogenous depression	0.000691	0.00861	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000665	0.00828	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.000644	0.00802	CbGpPWpGaD
Dexfenfluramine—HTR2B—cardiovascular system—endogenous depression	0.00064	0.0361	CbGeAlD
Dexfenfluramine—CYP2C9—Xenobiotics—CYP2D6—endogenous depression	0.00063	0.00785	CbGpPWpGaD
Dexfenfluramine—HTR2B—Monoamine GPCRs—HTR2A—endogenous depression	0.000629	0.00783	CbGpPWpGaD
Dexfenfluramine—HTR2C—Amine ligand-binding receptors—HTR7—endogenous depression	0.000609	0.00758	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000606	0.00755	CbGpPWpGaD
Dexfenfluramine—Methamphetamine—CYP2D6—endogenous depression	0.000584	0.142	CrCbGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000568	0.00708	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Xenobiotics—CYP2D6—endogenous depression	0.000538	0.00671	CbGpPWpGaD
Dexfenfluramine—HTR2C—midbrain—endogenous depression	0.000532	0.03	CbGeAlD
Dexfenfluramine—HTR2B—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000529	0.00658	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000518	0.00645	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.000513	0.00639	CbGpPWpGaD
Dexfenfluramine—HTR2C—Monoamine GPCRs—HTR2A—endogenous depression	0.000507	0.00632	CbGpPWpGaD
Dexfenfluramine—HTR2B—adrenal gland—endogenous depression	0.000506	0.0286	CbGeAlD
Dexfenfluramine—SLC6A4—midbrain—endogenous depression	0.000505	0.0285	CbGeAlD
Dexfenfluramine—CYP2A6—cerebellum—endogenous depression	0.000503	0.0284	CbGeAlD
Dexfenfluramine—HTR2B—thyroid gland—endogenous depression	0.000489	0.0276	CbGeAlD
Dexfenfluramine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000471	0.00586	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000464	0.00578	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—TPH1—endogenous depression	0.000464	0.00578	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Tryptophan metabolism—TPH1—endogenous depression	0.000456	0.00568	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Estrogen metabolism—COMT—endogenous depression	0.000444	0.00553	CbGpPWpGaD
Dexfenfluramine—SLC6A4—endocrine gland—endogenous depression	0.000443	0.025	CbGeAlD
Dexfenfluramine—HTR2C—nervous system—endogenous depression	0.000438	0.0247	CbGeAlD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000431	0.00537	CbGpPWpGaD
Dexfenfluramine—HTR2C—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000427	0.00531	CbGpPWpGaD
Dexfenfluramine—HTR2C—central nervous system—endogenous depression	0.000421	0.0238	CbGeAlD
Dexfenfluramine—CYP2C9—cardiovascular system—endogenous depression	0.000415	0.0234	CbGeAlD
Dexfenfluramine—SLC6A4—nervous system—endogenous depression	0.000415	0.0234	CbGeAlD
Dexfenfluramine—HTR2B—nervous system—endogenous depression	0.000411	0.0232	CbGeAlD
Dexfenfluramine—CYP2A6—brain—endogenous depression	0.000408	0.023	CbGeAlD
Dexfenfluramine—CYP1A2—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.0004	0.00498	CbGpPWpGaD
Dexfenfluramine—SLC6A4—central nervous system—endogenous depression	0.000399	0.0225	CbGeAlD
Dexfenfluramine—HTR2B—central nervous system—endogenous depression	0.000396	0.0223	CbGeAlD
Dexfenfluramine—CYP2E1—cardiovascular system—endogenous depression	0.000393	0.0222	CbGeAlD
Dexfenfluramine—CYP2C19—Melatonin metabolism and effects—MAOA—endogenous depression	0.000386	0.00481	CbGpPWpGaD
Dexfenfluramine—CYP2D6—brainstem—endogenous depression	0.000382	0.0215	CbGeAlD
Dexfenfluramine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000382	0.00475	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000372	0.00463	CbGpPWpGaD
Dexfenfluramine—CYP2D6—forebrain—endogenous depression	0.000368	0.0208	CbGeAlD
Dexfenfluramine—CYP2C19—endocrine gland—endogenous depression	0.000367	0.0207	CbGeAlD
Dexfenfluramine—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000367	0.00457	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000357	0.00444	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000355	0.00443	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—TPH2—endogenous depression	0.000352	0.00438	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000344	0.00429	CbGpPWpGaD
Dexfenfluramine—HTR2C—brain—endogenous depression	0.000334	0.0189	CbGeAlD
Dexfenfluramine—CYP1A2—thyroid gland—endogenous depression	0.000334	0.0188	CbGeAlD
Dexfenfluramine—SLC6A4—brain—endogenous depression	0.000317	0.0179	CbGeAlD
Dexfenfluramine—HTR2B—brain—endogenous depression	0.000314	0.0177	CbGeAlD
Dexfenfluramine—CYP2E1—adrenal gland—endogenous depression	0.000311	0.0175	CbGeAlD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—CRH—endogenous depression	0.000302	0.00377	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000302	0.00376	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Melatonin metabolism and effects—MAOA—endogenous depression	0.000301	0.00375	CbGpPWpGaD
Dexfenfluramine—CYP2E1—thyroid gland—endogenous depression	0.0003	0.0169	CbGeAlD
Dexfenfluramine—CYP1A2—endocrine gland—endogenous depression	0.0003	0.0169	CbGeAlD
Dexfenfluramine—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000287	0.00358	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000287	0.00357	CbGpPWpGaD
Dexfenfluramine—CYP2C9—endocrine gland—endogenous depression	0.000285	0.0161	CbGeAlD
Dexfenfluramine—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000283	0.00353	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—OXT—endogenous depression	0.000275	0.00343	CbGpPWpGaD
Dexfenfluramine—CYP2E1—endocrine gland—endogenous depression	0.00027	0.0152	CbGeAlD
Dexfenfluramine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000262	0.00326	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000259	0.00323	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000258	0.00322	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—HTR2C—endogenous depression	0.000256	0.00319	CbGpPWpGaD
Dexfenfluramine—CYP2E1—nervous system—endogenous depression	0.000253	0.0142	CbGeAlD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00025	0.00311	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—HTR7—endogenous depression	0.000246	0.00307	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000246	0.00307	CbGpPWpGaD
Dexfenfluramine—CYP2E1—central nervous system—endogenous depression	0.000243	0.0137	CbGeAlD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000239	0.00297	CbGpPWpGaD
Dexfenfluramine—CYP2E1—cerebellum—endogenous depression	0.000238	0.0134	CbGeAlD
Dexfenfluramine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000233	0.0029	CbGpPWpGaD
Dexfenfluramine—CYP2A6—NRF2 pathway—SLC6A4—endogenous depression	0.000231	0.00288	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000231	0.00287	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000229	0.00285	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000227	0.00283	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000224	0.00278	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—OXT—endogenous depression	0.000222	0.00277	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000221	0.00275	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000221	0.00275	CbGpPWpGaD
Dexfenfluramine—CYP2D6—endocrine gland—endogenous depression	0.000214	0.012	CbGeAlD
Dexfenfluramine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000212	0.00264	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000211	0.00263	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000205	0.00255	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—CYP2D6—endogenous depression	0.000203	0.00252	CbGpPWpGaD
Dexfenfluramine—CYP2D6—nervous system—endogenous depression	0.0002	0.0113	CbGeAlD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000199	0.00247	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000198	0.00246	CbGpPWpGaD
Dexfenfluramine—CYP2E1—brain—endogenous depression	0.000193	0.0109	CbGeAlD
Dexfenfluramine—CYP2D6—central nervous system—endogenous depression	0.000193	0.0109	CbGeAlD
Dexfenfluramine—CYP2D6—cerebellum—endogenous depression	0.000188	0.0106	CbGeAlD
Dexfenfluramine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000187	0.00233	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000182	0.00227	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000182	0.00227	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000181	0.00226	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000176	0.00219	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000175	0.00218	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000173	0.00216	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00017	0.00211	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—ADM—endogenous depression	0.000166	0.00206	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000165	0.00206	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000161	0.00201	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—CYP2D6—endogenous depression	0.00016	0.00199	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00016	0.00199	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metapathway biotransformation—CYP2D6—endogenous depression	0.000158	0.00197	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—HTR2A—endogenous depression	0.000157	0.00196	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—COMT—endogenous depression	0.000154	0.00191	CbGpPWpGaD
Dexfenfluramine—CYP2D6—brain—endogenous depression	0.000153	0.00862	CbGeAlD
Dexfenfluramine—CYP2A6—Biological oxidations—MAOA—endogenous depression	0.000153	0.0019	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000148	0.00185	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000148	0.00184	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000147	0.00183	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000142	0.00176	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000141	0.00175	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.00014	0.00175	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00014	0.00174	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CRH—endogenous depression	0.000139	0.00173	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—OXT—endogenous depression	0.000139	0.00173	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000136	0.0017	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—ADM—endogenous depression	0.000134	0.00166	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR1A—endogenous depression	0.000134	0.00166	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000129	0.00161	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR2C—endogenous depression	0.000129	0.00161	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000128	0.0016	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—HTR2A—endogenous depression	0.000127	0.00158	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase II conjugation—COMT—endogenous depression	0.000125	0.00155	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.000124	0.00154	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.000122	0.00152	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—COMT—endogenous depression	0.000121	0.00151	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000121	0.00151	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—MAOA—endogenous depression	0.000121	0.0015	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00012	0.00149	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metapathway biotransformation—COMT—endogenous depression	0.00012	0.00149	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000114	0.00142	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000113	0.00141	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR7—endogenous depression	0.000113	0.00141	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.000113	0.0014	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—OXT—endogenous depression	0.000112	0.0014	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CRH—endogenous depression	0.000112	0.0014	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.000111	0.00138	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00011	0.00136	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HTR1A—endogenous depression	0.000108	0.00134	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000105	0.00131	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000104	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000104	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—POMC—endogenous depression	9.93e-05	0.00124	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	9.79e-05	0.00122	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—CYP2D6—endogenous depression	9.63e-05	0.0012	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—CYP2D6—endogenous depression	9.5e-05	0.00118	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—COMT—endogenous depression	9.37e-05	0.00117	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—ADM—endogenous depression	9.36e-05	0.00117	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—MAOA—endogenous depression	9.3e-05	0.00116	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	9.24e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HTR7—endogenous depression	9.12e-05	0.00114	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	8.88e-05	0.00111	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—COMT—endogenous depression	8.61e-05	0.00107	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—MAOA—endogenous depression	8.55e-05	0.00107	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—COMT—endogenous depression	8.54e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—ADM—endogenous depression	8.5e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	8.5e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—MAOA—endogenous depression	8.48e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	8.42e-05	0.00105	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	8.39e-05	0.00104	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	8.3e-05	0.00103	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR2A—endogenous depression	7.92e-05	0.000986	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—POMC—endogenous depression	7.85e-05	0.000977	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CRH—endogenous depression	7.85e-05	0.000977	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—OXT—endogenous depression	7.85e-05	0.000977	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—ADM—endogenous depression	7.55e-05	0.000941	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR1A—endogenous depression	7.55e-05	0.000941	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—COMT—endogenous depression	7.3e-05	0.000909	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR2C—endogenous depression	7.3e-05	0.000908	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—MAOA—endogenous depression	7.25e-05	0.000902	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—COMT—endogenous depression	7.2e-05	0.000896	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CRH—endogenous depression	7.13e-05	0.000887	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—OXT—endogenous depression	7.13e-05	0.000887	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—ADM—endogenous depression	6.86e-05	0.000854	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR1A—endogenous depression	6.86e-05	0.000854	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	6.7e-05	0.000834	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR2C—endogenous depression	6.62e-05	0.000825	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR7—endogenous depression	6.39e-05	0.000796	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HTR2A—endogenous depression	6.39e-05	0.000796	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CRH—endogenous depression	6.33e-05	0.000788	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—OXT—endogenous depression	6.33e-05	0.000788	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—POMC—endogenous depression	6.32e-05	0.000788	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HTR1A—endogenous depression	6.09e-05	0.000759	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—POMC—endogenous depression	6.05e-05	0.000754	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR7—endogenous depression	5.8e-05	0.000723	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CRH—endogenous depression	5.75e-05	0.000716	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—OXT—endogenous depression	5.75e-05	0.000716	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—TPH1—endogenous depression	5.72e-05	0.000712	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—POMC—endogenous depression	5.57e-05	0.000693	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR1A—endogenous depression	5.53e-05	0.000689	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—POMC—endogenous depression	5.52e-05	0.000687	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—WASF2—endogenous depression	5.49e-05	0.000684	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—WASF1—endogenous depression	5.27e-05	0.000656	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HTR7—endogenous depression	5.15e-05	0.000642	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—POMC—endogenous depression	5.1e-05	0.000635	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ADM—endogenous depression	5.02e-05	0.000626	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—POMC—endogenous depression	4.72e-05	0.000587	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR7—endogenous depression	4.68e-05	0.000583	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—TPH1—endogenous depression	4.52e-05	0.000563	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR2A—endogenous depression	4.48e-05	0.000557	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—WASF2—endogenous depression	4.43e-05	0.000552	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—TPH2—endogenous depression	4.34e-05	0.00054	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CACNB2—endogenous depression	4.34e-05	0.00054	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—DPYD—endogenous depression	4.27e-05	0.000531	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—WASF1—endogenous depression	4.25e-05	0.000529	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—OXT—endogenous depression	4.21e-05	0.000524	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CRH—endogenous depression	4.21e-05	0.000524	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR2A—endogenous depression	4.06e-05	0.000506	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ADM—endogenous depression	4.05e-05	0.000505	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR1A—endogenous depression	4.05e-05	0.000505	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CACNA1C—endogenous depression	3.97e-05	0.000494	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR2C—endogenous depression	3.91e-05	0.000487	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HTR2A—endogenous depression	3.61e-05	0.00045	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—POMC—endogenous depression	3.57e-05	0.000445	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TPH1—endogenous depression	3.49e-05	0.000434	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP2D6—endogenous depression	3.47e-05	0.000432	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR7—endogenous depression	3.43e-05	0.000427	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—TPH2—endogenous depression	3.43e-05	0.000427	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CACNB2—endogenous depression	3.43e-05	0.000427	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—OXT—endogenous depression	3.4e-05	0.000423	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CRH—endogenous depression	3.4e-05	0.000423	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—DPYD—endogenous depression	3.37e-05	0.00042	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR2A—endogenous depression	3.28e-05	0.000408	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR1A—endogenous depression	3.27e-05	0.000407	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—POMC—endogenous depression	3.25e-05	0.000404	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TPH1—endogenous depression	3.21e-05	0.0004	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TPH1—endogenous depression	3.18e-05	0.000396	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CACNA1C—endogenous depression	3.13e-05	0.00039	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—POMC—endogenous depression	2.88e-05	0.000359	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR7—endogenous depression	2.77e-05	0.000344	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP2D6—endogenous depression	2.74e-05	0.000341	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TPH1—endogenous depression	2.72e-05	0.000338	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TPH2—endogenous depression	2.64e-05	0.000329	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CACNB2—endogenous depression	2.64e-05	0.000329	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—COMT—endogenous depression	2.63e-05	0.000327	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—POMC—endogenous depression	2.62e-05	0.000326	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—MAOA—endogenous depression	2.61e-05	0.000325	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—DPYD—endogenous depression	2.6e-05	0.000324	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CACNB2—endogenous depression	2.43e-05	0.000303	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TPH2—endogenous depression	2.43e-05	0.000303	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CACNA1C—endogenous depression	2.42e-05	0.000301	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TPH2—endogenous depression	2.41e-05	0.0003	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CACNB2—endogenous depression	2.41e-05	0.0003	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR2A—endogenous depression	2.4e-05	0.000299	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—DPYD—endogenous depression	2.39e-05	0.000298	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—DPYD—endogenous depression	2.37e-05	0.000295	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.32e-05	0.00029	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.22e-05	0.000277	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CACNA1C—endogenous depression	2.2e-05	0.000275	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.12e-05	0.000264	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP2D6—endogenous depression	2.11e-05	0.000263	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—COMT—endogenous depression	2.08e-05	0.000259	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MAOA—endogenous depression	2.06e-05	0.000257	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TPH2—endogenous depression	2.06e-05	0.000257	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CACNB2—endogenous depression	2.06e-05	0.000257	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—DPYD—endogenous depression	2.03e-05	0.000252	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR2A—endogenous depression	1.94e-05	0.000241	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP2D6—endogenous depression	1.93e-05	0.00024	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—POMC—endogenous depression	1.92e-05	0.000239	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CACNA1C—endogenous depression	1.88e-05	0.000235	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	1.81e-05	0.000226	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—POMC—endogenous depression	1.7e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2D6—endogenous depression	1.65e-05	0.000205	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—COMT—endogenous depression	1.6e-05	0.000199	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MAOA—endogenous depression	1.59e-05	0.000198	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—POMC—endogenous depression	1.55e-05	0.000193	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—COMT—endogenous depression	1.47e-05	0.000183	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MAOA—endogenous depression	1.46e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—COMT—endogenous depression	1.46e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MAOA—endogenous depression	1.45e-05	0.000181	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—POMC—endogenous depression	1.34e-05	0.000167	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—COMT—endogenous depression	1.25e-05	0.000155	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MAOA—endogenous depression	1.24e-05	0.000154	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—POMC—endogenous depression	1.04e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—POMC—endogenous depression	9.52e-06	0.000119	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—POMC—endogenous depression	9.44e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—POMC—endogenous depression	8.07e-06	0.0001	CbGpPWpGaD
